About NeuroQore
NeuroQore is a company based in Ottawa (Canada) founded in 2012. It operates as a HealthTech. NeuroQore has raised $1.76 million across 2 funding rounds from investors including IndieBio. NeuroQore offers products and services including Neuromodulation Treatment. NeuroQore operates in a competitive market with competitors including Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others.
- Headquarter Ottawa, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.76 M (USD)
in 2 rounds
-
Latest Funding Round
$1.51 M (USD), Series A
Jul 14, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroQore
NeuroQore offers a comprehensive portfolio of products and services, including Neuromodulation Treatment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative neuromodulation treatments for neurobehavioral conditions are developed.
Funding Insights of NeuroQore
NeuroQore has successfully raised a total of $1.76M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.51 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $1.5M
-
First Round
First Round
(07 Oct 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series A - NeuroQore | Valuation |
investors |
|
| Oct, 2016 | Amount | Seed - NeuroQore | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroQore
NeuroQore has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroQore
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroQore
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuroqore Comparisons
Competitors of NeuroQore
NeuroQore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of a wearable device for stress and anxiety management
|
|
| domain | founded_year | HQ Location |
Non-invasive TMS therapy is provided for major depressive disorder treatment.
|
|
| domain | founded_year | HQ Location |
Neurotechnology solutions for EEG, TMS, and tDCS are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation devices for mood disorders are manufactured.
|
|
| domain | founded_year | HQ Location |
Wearable devices are developed to modulate tissues for neurological diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuroqore
Frequently Asked Questions about NeuroQore
When was NeuroQore founded?
NeuroQore was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Where is NeuroQore located?
NeuroQore is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Is NeuroQore a funded company?
NeuroQore is a funded company, having raised a total of $1.76M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Oct 07, 2016.
What does NeuroQore do?
NeuroQore is engaged in the development of pioneering neuromodulation treatments targeting various neurobehavioral conditions, with a primary focus on major depressive disorder and suicidality. Collaboration with world-class universities and research clinics is maintained to explore transformative solutions. The healthcare gap in effective interventions for treatment-resistant depression and acute suicidality is addressed through innovative approaches. Efforts are directed towards creating impactful solutions for devastating disorders affecting millions globally.
Who are the top competitors of NeuroQore?
NeuroQore's top competitors include NeuroStar, Flow Neuroscience and Magstim.
What products or services does NeuroQore offer?
NeuroQore offers Neuromodulation Treatment.
Who are NeuroQore's investors?
NeuroQore has 1 investor. Key investors include IndieBio.